[1]
“END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION: Challenges in Supportive Care, Equity, and Compassion at End of Life”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026015, Jan. 2026, doi: 10.4084/MJHID.2026.015.